The paper reports the first attempt at the method of changing cooling treatment of synthesizing in order to investigate its effect on the physical properties of sol-gel derived nano-bioactive glass-ceramics in the system 58SiO 2 -33CaO--9P 2 O 5 (wt.%). We hypothesized that the method of cooling may affect the properties of nano-bioactive glass-ceramics. To test this hypothesis, two different methods of cooling treatment were applied after calcinations in the synthesis. Both quenched and unquenched nano-bioactive glass-ceramics were soaked in Ringer's solution with bovine serum albumin (BSA) for bioactivity evaluation. The obtained samples were analyzed for their composition, crystallinity and morphology using X-ray powder diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), surface electron microscopy (SEM) and transmission electron microscopy (TEM). The SEM images showed that the morphology of nano-bioactive glass-ceramics was completely changed by the quenching process. The results of in vitro bioactivity evaluation revealed that the unquenched sample attained faster apatite formation ability than the quenched sample. Other properties of these two morphologically different nano-bioactive glass-ceramics are discussed.
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As a third-generation biomaterial, bioactive glass-ceramics not only exhibit excellent bioactivity in the body, but also could bond to hard and soft tissue. Therefore, they have been used extensively as tissue engineering scaffolds, bone grafts and implant coatings [1] [2] [3] . The widespread use of bioactive glassceramics can be attributed to their ability of degrading in physiological solutions, developing an apatite-like layer similar to bone mineral which stimulate cells to proliferate and regenerate hard tissue [5] [6] [7] .
The first bioactive glass was developed by Hench in 1969 by melting a mixture of the related oxide precursors at relatively high temperatures. Sol-gel processing technology at low temperatures, an alternative to traditional melt processing of glasses, involves the synthesis of a solution (sol), typically composed of metal organic and metal salt precursors followed by the formation of a gel by chemical reaction or aggregation, and lastly thermal treatment for drying, organic removal, and sometimes crystallization and cooling treatment [8, 9] . Results from both in vitro studies in simulated body fluid [10] [11] [12] [13] and in vivo tests in animals showed that the sol-gel derived bioactive glasses were more bioactive and degradable than meltderived ones [14, 15] .
The widely accepted mechanism of HA formation involves the dissolution of calcium ions from the surface of bioactive materials, which increases the super-saturation in the surrounding fluid, with respect to HA components. The simultaneous dissolution of silicates results in the formation of silanol groups on the material's surface, which are essential for nucleation sites leading to HA formation [16] .
Depending on their composition, particle size, structural properties and synthetic process, bioceramics show varying degrees of bioactivity, which can be defined as the ability to chemically bond and integrate with living bone without fibrous tissue formation through the formation of HA [17] [18] [19] .
To study in vitro bioactivity of nano-bioactive glass-ceramics in physiological liquids, Bovine serum albumin (BSA) can be used as it is one of the most interesting proteins involved in biological events because it is present in a wide spread body liquid, i.e., the blood. Furthermore, the structure and physicochemical properties of albumin are well characterrized [20] [21] [22] [23] [24] [25] and it is one of the first proteins to come into contact with an implanted bioceramic [26] .
Recently, attention has been focused on the development of new bioactive glass-ceramics due to different applications based on the preparation methods, the change in chemical compositions and different heat treatment conditions [27] [28] [29] . For instance, the crystallization behaviour and the phase formation order of different crystals with increase in temperature have been explored by Aboud et al. [30] on SiO 2 --P 2 O 5 -Al 2 O 3 -MgO-Na 2 O glasses. The changes in physical properties of bioactive glasses with different thermal treatment have been investigated [31] . It seems that the final cooling treatment will also change the properties of bioactive glass-ceramics. It should be mentioned that no research studies have reported what would happen if the final cooling treatment of sol-gel process was changed. The aim of this study is threefold: first, to synthesize quenched/unquenched bioactive glass-ceramics through different cooling treatment method; second, to soak them in Ringer's solution with BSA in order to investigate their bioactivity; and third, to investigate the effect of changing final cooling treatment on the properties of bioactive glass-ceramics.
MATERIALS AND METHODS
The composition studied was bioactive glass 58S (58% SiO 2 -33% CaO-9% P 2 O 5 , based on mol%). The sol-gel precursors used in this study were tetraethyl orthosilicate (TEOS), triethyl phosphate (TEP), calcium nitrate tetrahydrate (Ca(NO 3 ) 2 ·4H 2 O), distilled water, 1 M ammonia, 2 M nitric acid (Merck, Germany). No additional purification was performed on the materials. Nano-bioactive glass preparation TEOS was used as the silica precursor mixed with nitric acid (HNO 3 ) and distilled water. Hydroxypropyl cellulose as a surfactant was dissolved in distilled water and stirred at room temperature for 1 day to become a homogeneous mixture and then was used instead of distilled water in the sol-gel bioactive glass preparation method. Ethanol, as an alcoholic medium, was added to the solution and allowed to react for 30 min for the acid hydrolysis of TEOS to proceed almost to completion. The following reagents were added in sequence allowing 20 min for each reagent to react completely: TEP, Ca(NO 3 ) 2 ·4H 2 O, ammonia solution. After the final addition, mixing was continued until the gel was formed. The gel was kept in the oven and heated at 70 °C for one day to remove the residual water and ethanol. During about 3 h the temperature was raised to 600 °C slowly and then the gel was calcined for 2 additional hours at 600 °C to stabilize the glass-ceramic and eliminate residual nitrate.
Method of quenching process
After all calcinations, two different methods were applied for cooling the dried and calcined nano-bioactive glass-ceramic powder. The sample was divided into two parts: the first section was taken out of the oven and cooled at room temperature (sample BG-q) and the second one was allowed to cool to room temperature slowly in oven (sample BG).
Preparation of simulated body fluid solution for bioactivity evaluation
In this study, the simulated body fluid was prepared by dissolving Bovine serum albumin (BSA) (Merck, Germany) in Ringer's solution to give concentrations of 10 and 20 mg/ml. Both synthesized powder samples were separately immersed in Ringer's solution with BSA. The solutions were stirred for 21 days and then dried at room temperature. The prepared samples are listed in Table 1 . 
Characterization tests
Scanning electron microscopy (SEM XL30) and transmission electron microscopy (TEM 208S) were used to characterize the morphology and grain size of nano-bioactive glass-ceramic powders. The samples were coated with gold before the examination. The functional group analysis was performed by Fourier Transform Infrared Spectroscopy (FT-IR). The measurements were carried out in the transmission mode in the mid-infrared range (400-4000 cm −1 ). The crystal structure and the phase present in resulting powders were analyzed with X-ray diffraction (XRD). This instrument (Philips PW 3710) works with voltage and current settings of 30 kV and 35 mA, respectively, and uses Cu-Kα radiation (1.540510 Å). For qualitative analysis, XRD diagrams were recorded in the interval 20° ≤ 2θ ≤ 50° at scan speed of 2 °/min. The crystallite size of the synthesized particle was calculated following Scherrer's equation:
where D is the crystallite size (nm), λ is wavelength of X-ray radiation (1.54056 Å), θ is the Bragg angle, and B is the full width at half maximum.
RESULTS AND DISCUSSION
Microscopic analysis SEM images of produced nano-bioactive glassceramic powders that could be used to study the size, morphology and homogeneity of samples are shown in Figures 1 and 2 , for samples BG and BG-q, respectively. It is obvious from these figures that the particle size ranges in nano size. It can be related to the method from which the bioglass-ceramic has been synthesized. It can also be concluded that morphology of samples changed completely by different final cooling treatment (quenching process). The shape of unquenched glass-ceramic is spherical but the quenched one is needle-shaped due to sudden exposure to cold room temperature.
It is also indicated from the TEM micrograph of nano-bioactive glass-ceramic (Figure 3 ) that most spherical particle sizes were from 20 to 40 nm while some small particles were conglomerated even though their size were also less than 60 nm. Needle-shaped quenched bioactive glass-ceramic can be clearly seen in Figure 4 as well. Figures 5 and 6 show SEM pictures of samples BG-BS10 and BG-q-BS10, respectively. Compared to Figures 1 and 2 , it can be mentioned that in both samples, the apatite (as shown in FTIR results) particles can be seen, which formed on the surface after soaking in Ringer's solution with BSA. 
XRD Analysis
The XRD patterns of samples BG and BG-q (Figure 7 ) confirm the formation of the bioactive glass-ceramic nano-powders. It can be detected that β-TCP and wollastonite (pseudowollastonite, JCPDS No. 19-0248) are the main phases in the bioglassceramic samples. It has been reported that pseudowollastonite is a bioactive material, and its in vitro and in vivo tests have been investigated [32] [33] [34] [35] [36] . Pseudowollastonite is a bioactive ceramic material that induces direct bone growth [37, 38] . There is another peak in these XRD patterns which is related to unreacted SiO 2 . It is obvious that XRD pattern of the sample BG-q is the same as the sample BG which means that quenching process did not affect phases of bioactive glass-ceramic. To confirm formation of apatite in Ringer's solution with BSA, XRD patterns of samples BG-BS10 and BG-q-BS10 are shown in Figure 8 . In addition to the aforementioned peaks, there are peaks that were assigned to be apatite according to the standard JCPDS cards (09-0432). The intensity and quality of peaks in sample BG-BS10 are improved in relation to sample BG-q-BS10. Thus the unquenched exhibits better bioactive behavior than the quenched sample. The peak related to unreacted SiO 2 remained the same as in Figure 7 , which means SiO 2 did not take part in Ringer's solution with BSA. The effect of concentration of BSA on the bioactivity of both quenched and unquenched samples is shown in Figures 9 and 10 . It is clear that the bioactivity of quenched samples increases and bioactivity of unquenched ones decreases when the concentration of BSA increases from 10 to 20, because the method of quenching affected the bioactivity of samples due to different porosity. Since the porosity of quenched bioactive glass-ceramics were higher than unquenched ones, the interaction between the quenched samples and BSA in higher concentration of Ringer's solution with BSA was higher than that between unquenched ones and BSA [39] . 
FT-IR Analysis
FT-IR Spectra of the bioglass-ceramic particles prepared at different final cooling treatment (sample BG and BG-q) were compared. No obvious distinction was seen between these two samples, which means their compositions were not changed by changing the final cooling treatment. FT-IR spectra related to both samples is presented in Figure 11A . Two broad and strong absorption bands at 1082 and 3435 cm -1 could be ascribed to stretching vibration of Si-O-Si and O-H bonds, respectively. The small band appearing around 800 cm -1 was the typical absorption band of symmetric stretching vibration of Si-O, while the absorption band at 470 cm -1 was attributed to bending vibration of Si-O. A dispersive band that arose from the bending vibration of amorphous P-O appeared in the vicinity of 575 cm -1 [40, 41] . The peak at 1480 cm -1 was attributed to the presence of C-O bond with respect to the experimental conditions leading to the mineralization in the atmosphere with some water and carbon dioxide [42] . The peak at 884 cm -1 was related to carbonate groups [43] [44] [45] . Figure 11B shows the FTIR spectra of sample BG and BG-q after soaking in Ringer's solution with BSA (sample BG-BS10 and BG-q-BS10). Additional peaks appeared in the FTIR spectra after soaking in Ringer's solution with BSA. The HA signature in this IR spectral range consists of two bands around 595 and 615 cm -1 [46] which indicate HA formation in simulated body fluid based on Ringer's solution. The peak at 1647 cm -1 was attributed to vibration of CO 3 2-and twin bands around 1400-1500 cm -1 could be assigned to the presence of C-O bond, attributed to the formation of crystalline hydroxycarbonate apatite (HCA).
CONCLUSIONS
The present work showed that the sol-gel low temperature process could be useful for producing quenched/unquenched nano-bioactive glass-ceramics. Different crystal morphologies of sol-gel bioglass-ceramics were obtained by new cooling treatment in synthesizing method and there was no change in the compositions and phases of quenched and unquenched samples. Further, the biocompatibility analysis confirmed the growth of HCAp on the surface of the bioglass-ceramic particles. The bioactivity of samples was changed by different concentrations of BSA. The new quenching method is better for higher concentration of BSA. It can be concluded that the method of cooling treatment will change the properties of bioactive glass-ceramics. Furthermore, it can be mentioned that these nano-bioactive glass-ceramics have the potential to be used as new scaffold materials for bone tissue engineering due to their bioactivity.
